Institut Bergonié: Prostatic Neoplasms trials

The registry lists 10 Prostatic Neoplasms studies with Institut Bergonié as lead sponsor. 2 are open to participants now and 5 have results posted.

Phase 2 2No phase 8(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Clinical and Dosimetric Study of Patients Treated With 177Lu-PSMA-617 for Prostate Cancer.RecruitingNCT06700057
• Randomized Phase II Trial on Short Term Darolutamide Concomitant to Radiation Therapy for Patients With Intermediate Unfavorable Risk Prostate CancerRecruitingNCT05346848Phase 2
• Modeling Clinical Failure in Prostate Cancer Patients Based on a Two-stage Statistical ModelCompletedNCT03979079Results posted
• Consensus Method to Evaluate the Conformity of Prescription of a ChemotherapyCompletedNCT02882178Results posted
• Expectations and Priorities of Elderly Patients for a First Medical Treatment for CancerCompletedNCT02821793Results posted
• Efavirenz in Treating Patients With Metastatic Prostate CancerCompletedNCT00964002Phase 2Results posted
• Validation of a Screening Tool in Geriatric OncologyCompletedNCT00963911Not applicableResults posted
• Streamlined Geriatric and Oncological Evaluation Based On IC TechnologyActive, not recruitingNCT05720910Not applicable
• Circulating And Intra-Tumoral Chemokines In Patients With Prostate CancerWithdrawnNCT02869282
• Role of Geriatric Intervention in Treatment of Older Patients With Cancer (PREPARE)CompletedNCT02704832Not applicable